Fibrogen-I Injection

Fibrinogen-I Injection contains an active component called as human fibrinogen. It treats bleeding episodes in people with a congenital Fibrinogen deficiency. These deficiencies can be caused by genetic mutations or by liver disease. It can be used as an adjunct to hemostasis (blood clotting) in adults undergoing surgery when control of bleeding by standard surgical techniques is ineffective or impractical. It is also used to help stop the bleeding and prevent further blood loss in cases of massive hemorrhage. It can be given to women who risk delivering their babies prematurely. It is also used in patients with acquired fibrinogen deficiency, which can be caused by liver disease, disseminated intravascular coagulation (DIC), afibrinogen-I Injectionemia, hypofibrinogenemia or other conditions that damage the liver or interfere with its production.

If you have had an allergic reaction to Fibrinogen-I Injection or other blood products in the past, you should not receive it.  It should not be given to people who are already actively bleeding. This is because it can increase the risk of forming a blood clot. If you have a history of thrombosis, you should not receive this medication without careful consideration. Special considerations are needed when administering this medication to pediatric and geriatric patients, including dosage adjustments based on age and weight and close monitoring.